Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$5.65 - $7.66 $260,905 - $353,723
-46,178 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$4.01 - $6.29 $51,328 - $80,512
-12,800 Reduced 21.7%
46,178 $261,000
Q2 2020

Aug 13, 2020

SELL
$3.06 - $6.6 $30,869 - $66,580
-10,088 Reduced 14.61%
58,978 $301,000
Q1 2020

May 13, 2020

BUY
$2.83 - $8.44 $195,456 - $582,917
69,066 New
69,066 $239,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.